Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price was down 4.2% on Tuesday . The stock traded as low as C$0.12 and last traded at C$0.12. Approximately 20,000 shares traded hands during trading, a decline of 84% from the average daily volume of 124,956 shares. The stock had previously closed at C$0.12.
Kane Biotech Price Performance
The stock has a market cap of C$15.24 million, a price-to-earnings ratio of -4.00 and a beta of 0.52. The company has a 50-day simple moving average of C$0.12 and a two-hundred day simple moving average of C$0.13. The company has a debt-to-equity ratio of 1,164.24, a quick ratio of 0.39 and a current ratio of 0.82.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Featured Stories
- Five stocks we like better than Kane Biotech
- What Are Dividend Achievers? An Introduction
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
- Using the MarketBeat Dividend Tax Calculator
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- How to Use the MarketBeat Excel Dividend Calculator
- Trending Stocks: How to Spot, Trade, and Profit Safely
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
